Zhenbing Lv
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Cancer-related gene regulation
- RNA Research and Splicing
- Redox biology and oxidative stress
Papers in
-
- Circular RNAs in diseases 3
- RNA modifications and cancer 3
- Cancer-related gene regulation 3
- RNA Research and Splicing 2
- Molecular Biology Techniques and Applications 2
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 5
- Co-authors
- Yongfu Xiong (5 shared papers)Xiaoli Ren (4 shared papers)Yanqing Ding (4 shared papers)Jinlai Wei (4 shared papers)Yuling Li (3 shared papers)Liang Li (3 shared papers)Guoyang He (2 shared papers)Wenting Liao (2 shared papers)
- Journals
- Oncotarget (4 papers)Bioorganic Chemistry (1 paper)DNA and Cell Biology (1 paper)Human & Experimental Toxicology (1 paper)Life (1 paper)
- Partner nations
- China
In The Last Decade
Zhenbing Lv
16 papers receiving 461 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 237
- Molecular Biology 373
- Oncology 66
- Cell Biology 27
- Geriatrics and Gerontology 6
Countries citing papers authored by Zhenbing Lv
This map shows the geographic impact of Zhenbing Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenbing Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenbing Lv more than expected).
Fields of papers citing papers by Zhenbing Lv
This network shows the impact of papers produced by Zhenbing Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenbing Lv. The network helps show where Zhenbing Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenbing Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 106 | |
| 2 | 2017 | 51 | |
| 3 | 2015 | 50 | |
| 4 | 2018 | 42 | |
| 5 | 2017 | 40 | |
| 6 | 2014 | 35 | |
| 7 | 2016 | 31 | |
| 8 | 2017 | 28 | |
| 9 | 2013 | 20 | |
| 10 | 2020 | 14 | |
| 11 | 2018 | 14 | |
| 12 | 2021 | 13 | |
| 13 | 2017 | 8 | |
| 14 | 2017 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2024 | 1 | |
| 17 | 2022 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Zhenbing Lv
Zhenbing Lv is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 20 papers that have together received 463 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (3 papers), RNA modifications and cancer (3 papers), Cancer-related gene regulation (3 papers), Cancer Cells and Metastasis (2 papers), RNA Research and Splicing (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Cancer Research (237 citations), Molecular Biology (373 citations), Oncology (66 citations), Cell Biology (27 citations) and Geriatrics and Gerontology (6 citations). Zhenbing Lv has collaborated with scholars based in China. Frequent co-authors include Yongfu Xiong, Xiaoli Ren, Yanqing Ding, Jinlai Wei, Yuling Li, Liang Li, Guoyang He, Wenting Liao, Zhongxue Fu and Wenxian You. Their work appears in journals such as Oncotarget, Bioorganic Chemistry, DNA and Cell Biology, Human & Experimental Toxicology and Life.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.